These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25679973)

  • 21. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.
    Lefrère F; Delmer A; Suzan F; Levy V; Belanger C; Djabarri M; Arnulf B; Damaj G; Maillard N; Ribrag V; Janvier M; Sebban C; Casasnovas RO; Bouabdallah R; Dreyfus F; Verkarre V; Delabesse E; Valensi F; McIntyre E; Brousse N; Varet B; Hermine O
    Leukemia; 2002 Apr; 16(4):587-93. PubMed ID: 11960337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current regimens and novel agents for mantle cell lymphoma.
    Chen Y; Wang M; Romaguera J
    Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group.
    Caballero D; Campo E; López-Guillermo A; Martín A; Arranz-Sáez R; Giné E; López A; González-Barca E; Canales MÁ; González-Díaz M; Orfao A
    Ann Hematol; 2013 Sep; 92(9):1151-79. PubMed ID: 23716187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
    Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
    J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mantle cell lymphoma: case report].
    Méhes L; Telek B; Udvardy M; Schlammadinger A; és Rejto L
    Orv Hetil; 2008 Aug; 149(31):1471-4. PubMed ID: 18632508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
    Kanaji N; Ishibashi K; Uno H; Hino N
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical features, therapeutic effects and prognosis of mantle cell lymphoma].
    Zhang HX; Xu J; Liu T; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):231-5. PubMed ID: 21569704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mantle cell lymphoma: advances in biology and therapy.
    Smith MR
    Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of younger patients with mantle cell lymphoma.
    Harel S; Delarue R; Ribrag V; Dreyling M; Hermine O
    Semin Hematol; 2011 Jul; 48(3):194-207. PubMed ID: 21782062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
    Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
    Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment strategies in mantle cell lymphoma.
    Maddocks K; Blum KA
    Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mantle cell lymphoma - Current standards of care and future directions.
    Martin P; Ghione P; Dreyling M
    Cancer Treat Rev; 2017 Jul; 58():51-60. PubMed ID: 28651117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapies for mantle cell lymphoma: current challenges and a brighter future.
    Skarbnik AP; Smith MR
    Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of mantle cell lymphoma].
    Udvardy M
    Orv Hetil; 2009 Dec; 150(50):2253-7. PubMed ID: 19951856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The modern approach to mantle cell lymphoma.
    Rule S
    Hematol Oncol; 2019 Jun; 37 Suppl 1():66-69. PubMed ID: 31187531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of mantle cell lymphoma.
    Hitz F; Bargetzi M; Cogliatti S; Lohri A; Taverna C; Renner C; Mey U
    Swiss Med Wkly; 2013; 143():w13868. PubMed ID: 24226630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.
    Gordon LI; Bernstein SH; Jares P; Kahl BS; Witzig TE; Dreyling M
    Leuk Lymphoma; 2014 Oct; 55(10):2262-70. PubMed ID: 24512319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.
    Shrestha R; Bhatt VR; Guru Murthy GS; Armitage JO
    Leuk Lymphoma; 2015; 56(10):2759-67. PubMed ID: 25747972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indolent mantle cell lymphoma.
    Hsi ED; Martin P
    Leuk Lymphoma; 2014 Apr; 55(4):761-7. PubMed ID: 23927395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.